Nelson, Van Denburg & Campbell Wealth Management Group, LLC Mersana Therapeutics, Inc. Transaction History

Nelson, Van Denburg & Campbell Wealth Management Group, LLC

$2.42 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$2.16 - $5.94 $47 - $130	22 New	22 $0
Q3 2021 Nov 02, 2021	SELL	$8.56 - $14.47 $96,274 - $162,744	-11,247 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$13.28 - $18.07 $9,468 - $12,883	713 Added 6.77%	11,247 $152,000
Q1 2021 May 11, 2021	BUY	$15.31 - $26.52 $161,275 - $279,361	10,534 New	10,534 $170,000

Others Institutions Holding MRSN

# of Institutions

121

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

Eco R1 Capital, LLC San Francisco, CA

19.4M
Shares

$39.5 Million
1.59% of portfolio
Nextech Invest Ag

12.1M
Shares

$24.6 Million
3.72% of portfolio
Vr Adviser, LLC New York, NY

11.3M
Shares

$23.1 Million
2.22% of portfolio
Bain Capital Life Sciences Investors, LLC Boston, MA

8.66M
Shares

$17.7 Million
2.94% of portfolio
Black Rock Inc. New York, NY

8.38M
Shares

$17.1 Million
0.0% of portfolio

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $198M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.

Account